Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BIVALIRUDIN
- BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation
- A Randomized, Double-Blind Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
- Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms
- Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI
- Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
- Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
- Bivalirudin in Late PCI for Oatients With STEMI
- Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)
- Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
- Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
- Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction
- Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI
- Bivalirudin vs Heparin in ECMO Patients
- Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
- Reduce Bolus Injection of Bivalirudin
- Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)
- A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
- Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
- Bivalirudin in Acute Myocardial Infarction
- Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
- Bivalirudin Infusion for Ventricular Infarction Limitation
- Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
- Simplified Anti-Thrombotic Therapy for FFR
- Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
- Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
- ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial
- Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
- A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
- GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
- Rapid Activity of Platelet Inhibitor Drugs Study 2
- Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
- BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.
- Antithrombotic Effects of Ticagrelor Versus Clopidogrel
- ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
- Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
- How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
- Rapid Activity of Platelet Inhibitor Drugs Study
- Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients
- Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
- Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
- Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
- Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
- European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
- EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
- The INFUSE - Anterior Myocardial Infarction (AMI) Study
- Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
- The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
- Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
- Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
- Anticoagulant Treatments and Percutaneous Coronary Angioplasty
- ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
- Bivalirudin as a Procedural Anticoagulant in Pediatrics
- Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
- Antithrombotic Regimens and Outcome
- Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
- Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
- ImproveR International (BI-001-IM)
- Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
- Safety and Dosing Evaluation of REG1 Anticoagulation System
- Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
- Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
- Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
- Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
- Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
- Study Of Angiomax In Infants Under Six Months With Thrombosis
Clinical trials list
click for details